Annual CFF
$1.09 M
-$5.69 M-83.97%
December 31, 2023
Summary
- As of February 7, 2025, SCNI annual cash flow from financing activities is $1.09 million, with the most recent change of -$5.69 million (-83.97%) on December 31, 2023.
- During the last 3 years, SCNI annual CFF has fallen by -$3.18 million (-74.54%).
- SCNI annual CFF is now -95.59% below its all-time high of $24.61 million, reached on December 1, 2019.
Performance
SCNI Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$8000.00
-$4000.00-33.33%
September 1, 2024
Summary
- As of February 7, 2025, SCNI quarterly cash flow from financing activities is $8000.00, with the most recent change of -$4000.00 (-33.33%) on September 1, 2024.
- Over the past year, SCNI quarterly CFF has dropped by -$1.41 million (-99.44%).
- SCNI quarterly CFF is now -99.94% below its all-time high of $12.78 million, reached on September 1, 2017.
Performance
SCNI Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$1.44 M
-$1.08 M-42.79%
September 1, 2024
Summary
- As of February 7, 2025, SCNI TTM cash flow from financing activities is $1.44 million, with the most recent change of -$1.08 million (-42.79%) on September 1, 2024.
- Over the past year, SCNI TTM CFF has dropped by -$1.07 million (-42.52%).
- SCNI TTM CFF is now -93.56% below its all-time high of $22.39 million, reached on December 1, 2018.
Performance
SCNI TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
SCNI Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -84.0% | -99.4% | -42.5% |
| 3 y3 years | -74.5% | -99.9% | -78.7% |
| 5 y5 years | -95.2% | -99.9% | -78.7% |
SCNI Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -94.9% | at low | -99.9% | -100.0% | -81.7% | -100.0% |
| 5 y | 5-year | -95.6% | at low | -99.9% | -100.0% | -81.7% | -100.0% |
| alltime | all time | -95.6% | +640.8% | -99.9% | +102.4% | -93.6% | +608.1% |
Scinai Immunotherapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $8000.00(-33.3%) | $1.44 M(-42.8%) |
| Jun 2024 | - | $12.00 K(-99.2%) | $2.52 M(+0.5%) |
| Mar 2024 | - | $1.42 M(>+9900.0%) | $2.51 M(+130.8%) |
| Dec 2023 | $1.09 M(-84.0%) | $0.00(-100.0%) | $1.09 M(-86.2%) |
| Sep 2023 | - | $1.09 M(>+9900.0%) | $7.86 M(+16.0%) |
| Jun 2023 | - | $0.00(0.0%) | $6.78 M(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) | $6.78 M(0.0%) |
| Dec 2022 | $6.78 M(-68.4%) | $6.78 M(>+9900.0%) | $6.78 M(>+9900.0%) |
| Sep 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2021 | $21.43 M(+402.4%) | - | - |
| Dec 2020 | $4.27 M(-82.7%) | - | - |
| Dec 2019 | $24.61 M(+9.9%) | - | - |
| Jun 2019 | - | -$36.80 K(-57.5%) | $15.36 M(-31.1%) |
| Mar 2019 | - | -$86.50 K(-101.0%) | $22.30 M(-0.4%) |
| Dec 2018 | $22.39 M | $8.36 M(+17.3%) | $22.39 M(+57.1%) |
| Sep 2018 | - | $7.12 M(+3.1%) | $14.25 M(-28.4%) |
| Jun 2018 | - | $6.91 M(>+9900.0%) | $19.91 M(+34.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $0.00(-100.0%) | $14.78 M(-16.9%) |
| Dec 2017 | $17.79 M(>+9900.0%) | $220.00 K(-98.3%) | $17.79 M(+1.3%) |
| Sep 2017 | - | $12.78 M(+618.8%) | $17.57 M(+267.0%) |
| Jun 2017 | - | $1.78 M(-40.9%) | $4.79 M(+59.1%) |
| Mar 2017 | - | $3.01 M(>+9900.0%) | $3.01 M(>+9900.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2016 | - | $0.00(0.0%) | $56.00 K(-119.7%) |
| Jun 2016 | - | $0.00(0.0%) | -$283.60 K(-103.3%) |
| Mar 2016 | - | $0.00(-100.0%) | $8.69 M(+0.5%) |
| Dec 2015 | $8.65 M(-4406.0%) | $56.00 K(-116.5%) | $8.65 M(+3.1%) |
| Sep 2015 | - | -$339.60 K(-103.8%) | $8.39 M(-3.9%) |
| Jun 2015 | - | $8.97 M(<-9900.0%) | $8.73 M(-3670.2%) |
| Mar 2015 | - | -$43.70 K(-78.2%) | -$244.50 K(+21.8%) |
| Dec 2014 | -$200.80 K(-107.6%) | -$200.80 K(<-9900.0%) | -$200.80 K(<-9900.0%) |
| Sep 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00 | $0.00 |
| Dec 2013 | $2.66 M(+101.0%) | - | - |
| Dec 2012 | $1.32 M(+6.2%) | - | - |
| Dec 2011 | $1.24 M | - | - |
FAQ
- What is Scinai Immunotherapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics annual CFF year-on-year change?
- What is Scinai Immunotherapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics quarterly CFF year-on-year change?
- What is Scinai Immunotherapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics TTM CFF year-on-year change?
What is Scinai Immunotherapeutics annual cash flow from financing activities?
The current annual CFF of SCNI is $1.09 M
What is the all time high annual CFF for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high annual cash flow from financing activities is $24.61 M
What is Scinai Immunotherapeutics annual CFF year-on-year change?
Over the past year, SCNI annual cash flow from financing activities has changed by -$5.69 M (-83.97%)
What is Scinai Immunotherapeutics quarterly cash flow from financing activities?
The current quarterly CFF of SCNI is $8000.00
What is the all time high quarterly CFF for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high quarterly cash flow from financing activities is $12.78 M
What is Scinai Immunotherapeutics quarterly CFF year-on-year change?
Over the past year, SCNI quarterly cash flow from financing activities has changed by -$1.41 M (-99.44%)
What is Scinai Immunotherapeutics TTM cash flow from financing activities?
The current TTM CFF of SCNI is $1.44 M
What is the all time high TTM CFF for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high TTM cash flow from financing activities is $22.39 M
What is Scinai Immunotherapeutics TTM CFF year-on-year change?
Over the past year, SCNI TTM cash flow from financing activities has changed by -$1.07 M (-42.52%)